Neil F. McFarlane, President and CEO at ZEVRA THERAPEUTICS, INC. (ZVRA), sold 183,634 shares at $8.05 ($1.5M) on 2025-02-14, disclosed to the SEC on 2025-02-14.
Scheduled sale ($1.5M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.86 | 61,273 | $482K | 33.1% |
| 2 | $7.86 | 61,273 | $482K | 33.1% |
| 3 | $8.05 | 30,544 | $246K | 16.9% |
| 4 | $8.05 | 30,544 | $246K | 16.9% |
| Total | $7.92 avg | 183,634 | $1.5M | 100% |
| Filing → |
| ZVRA | SELL | 2026-02-02 | $1.7M | — | Filing → |
| ZVRA | SELL | 2025-10-10 | $211K | — | Filing → |
| RTRX | SELL | 2019-05-16 | $36K | — | Filing → |